Sanofi-aventis - One of the world's leading pharmaceutical companies
Dedicated to improving life through the discovery and development of innovative products in the fields of prescription drugs, vaccines, therapeutic proteins ...
http://www.sanofi-aventis.com/...
|
BioSpace - Sanofi-Synthelabo News, Search Jobs, Events
Sanofi-Synthelabo is a global healthcare company. With annual sales in excess of $5.5 billion and 30000 employees in more than 100 countries, ...
http://www.biospace.com/company_profile.aspx?CompanyId=3581...
|
Shareholders Approve Sanofi-Synthelabo Merger
PARIS, May 18 /PRNewswire/ -- The Annual General Meetings of Shareholders of Sanofi, Synthelabo and Sanofi-Synthelabo were held on May 18, 1999. ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
DailyMed: About DailyMed
[Sanofi-Synthelabo Inc.] Drug Label Sections ..... Sanofi-Synthelabo Inc. New York, NY 10016 by Searle Ltd. ... Revised: 12/2008Sanofi-Synthelabo Inc. ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=8745...
|
Sanofi-Synthelabo Announces Its Listing on the New York Stock Exchange
1 Jul 2002 ... Sanofi-Synthelabo's shares will be traded under the form of American Depositary Receipts (ADRs). The Sanofi-Synthelabo ADR will trade under ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
DailyMed: About DailyMed
Icon attached Review or Hide All RxNorm Normal Forms Link Review RxNorm Normal Forms. phisohex (hexachlorophene) emulsion [Sanofi-Synthelabo Inc.] ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=1783...
|
Sanofi-Synthelabo to Acquire All of Taisho's 49% Interest in the ...
4 /PRNewswire-FirstCall/ -- Sanofi-Synthelabo announced today that it has reached an agreement with Taisho Pharmaceutical Co. ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
DailyMed: About DailyMed
Sanofi-Synthelabo Inc. New York, NY 10016 by Bayer Corporation Myerstown, PA 17067. Made In USA ... Revised: 10/2008Sanofi-Synthelabo Inc. ...
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1BFBF4...
|
Sanofi-Synthelabo Annual General Meeting
PARIS, June 24 /PRNewswire-FirstCall/ -- The Combined General Meeting of Sanofi- Synthelabo shareholders was held on June 23, 2004. ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
Accelrys > Science > Case Studies > Modeling at Sanofi-Synthelabo
Modeling at Sanofi-Synthelabo - An Interview with David England, Physical Chemistry R&D ... Sanofi-Synthelabo has access to drug discovery,
crystallization, ...
http://accelrys.com/references/case-studies/archive/studies/...
|
